Itron, Inc.
87.65USD
-0.5200 (-0.59%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ITRI.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.56▲ | $1.56 | 6 | 2 |
| Next quarter | $1.78▲ | $1.66 | 8 | 1 |
| Current year | $6.42▲ | $5.97 | 11 | 0 |
| Next year | $7▲ | $6.56 | 9 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.29 | $1.59 | +0.30 (+23.7%) |
| 2026-03-31 | $1.24 | $1.49 | +0.25 (+20.3%) |
| 2025-12-31 | $2.19 | $2.46 | +0.27 (+12.4%) |
| 2025-09-30 | $1.48 | $1.54 | +0.06 (+4.3%) |
189 ratings from 32 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Needham | Maintained | Buy | $116 $128 | Jul 29, 2026 |
| Stephens & Co. | Reiterated | Overweight | $130 | May 20, 2026 |
| TD Cowen | Maintained | Buy | $145 $130 | Apr 29, 2026 |
| JP Morgan | Maintained | Overweight | $133 $113 | Apr 16, 2026 |
| Oppenheimer | Maintained | Outperform | $133 $135 | Apr 16, 2026 |
| Needham | Initiated | Buy | $124 | Mar 6, 2026 |
| Oppenheimer | Maintained | Outperform | $125 $133 | Feb 18, 2026 |
| Baird | Upgraded from Neutral | Outperform | $118 $128 | Feb 18, 2026 |
| Guggenheim | Downgraded from Buy | Neutral | — | Feb 17, 2026 |
| Guggenheim | Downgraded from Buy | Neutral | — | Feb 13, 2026 |
| Oppenheimer | Maintained | Outperform | $145 $125 | Jan 27, 2026 |
| Johnson Rice | Upgraded from Accumulate | Buy | $130 | Jan 5, 2026 |
| Argus Research | Downgraded from Buy | Hold | — | Nov 4, 2025 |
| Baird | Downgraded from Outperform | Neutral | $137 $118 | Oct 31, 2025 |
| JP Morgan | Maintained | Overweight | $145 $155 | Oct 16, 2025 |
| Stephens & Co. | Reiterated | Equal-Weight | $130 | Oct 7, 2025 |
| JP Morgan | Upgraded from Neutral | Overweight | $128 $145 | Jul 31, 2025 |
| Roth Capital | Maintained | Buy | $130 $150 | Jul 22, 2025 |
| JP Morgan | Maintained | Neutral | $118 $128 | Jul 22, 2025 |
| Guggenheim | Maintained | Buy | $133 $155 | Jul 14, 2025 |
| Piper Sandler | Maintained | Neutral | $124 $121 | May 5, 2025 |
| Guggenheim | Reiterated | Buy | $133 | Apr 17, 2025 |
| Guggenheim | Maintained | Buy | $135 $133 | Feb 27, 2025 |
| Piper Sandler | Maintained | Neutral | $119 $124 | Feb 27, 2025 |
| Canaccord Genuity | Maintained | Buy | $130 $132 | Feb 26, 2025 |
173 filings from 22 insiders · 15 buy / 32 sell over 6m
Officers and directors of ITRI, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Savage SheriDirector | Grant | 608 | — | — | Oct 1, 2026 |
| Perez SantiagoDirector | Grant | 608 | — | — | Oct 1, 2026 |
| Mirchandani SanjayDirector | Grant | 608 | — | — | Oct 1, 2026 |
| LEYDEN TIMOTHY MDirector | Grant | 243 | — | — | Oct 1, 2026 |
| Lande Jerome J.Director | Grant | 608 | — | — | Oct 1, 2026 |
| JAEHNERT FRANK MDirector | Grant | 608 | — | — | Oct 1, 2026 |
| Drury Scott D.Director | Grant | 608 | — | — | Oct 1, 2026 |
| Patrick Justin KOfficer, SVP, Device Solutions | Sell | 1.2k | $97.36 | $112k | Sep 3, 2026 |
| Patrick Justin KOfficer, SVP, Device Solutions | Sell | 581 | $97.36 | $57k | Sep 3, 2026 |
| Patrick Justin KOfficer, SVP, Device Solutions | Sell | 593 | $97.36 | $58k | Sep 3, 2026 |
| Patrick Justin KOfficer, SVP, Device Solutions | Sell | 7.9k | $97.36 | $767k | Sep 3, 2026 |
| REEVES DONALD L IIIOfficer | Sell | 283 | $99.99 | $28k | Aug 25, 2026 |
| HOOPER JOAN SChief Financial Officer | Sell | 455 | $98.79 | $45k | Aug 24, 2026 |
| DEITRICH THOMASChief Executive Officer | Sell | 887 | $98.79 | $88k | Aug 24, 2026 |
| PULATIE-HAHN LAURIE ANNOfficer | Sell | 178 | $98.79 | $18k | Aug 24, 2026 |
| WARE CHRISTOPHER EGeneral Counsel | Sell | 200 | $98.79 | $20k | Aug 24, 2026 |
| PATRICK JUSTIN KOfficer | Sell | 222 | $98.79 | $22k | Aug 24, 2026 |
| MARCOLINI JOHN FOfficer | Sell | 331 | $98.79 | $33k | Aug 24, 2026 |
| WRIGHT DAVID MARSHALLOfficer | Sell | 76 | $98.79 | $8k | Aug 24, 2026 |
| REEVES DONALD L IIIOfficer | Sell | 329 | $98.79 | $33k | Aug 24, 2026 |
No analyst notes on ITRI yet.
Analyst Ratings
9 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 6 | 2 | 0 | 0 | Buy1.91 |
| 1 mo ago | 3 | 7 | 2 | 0 | 0 | Buy1.92 |
| 2 mo ago | 3 | 7 | 2 | 0 | 1 | Buy2.15 |
Members whose judged calls on ITRI have played out most reliably.
No settled calls on ITRI yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice